23andMe to receive US$60m in funding to sequence Parkinson’s genomes

January 7, 2015 11:38 AM

11 0

The deal comes despite efforts by the US Food and Drug Administration (FDA) to shut down the company for what it deemed a violation of the law by providing genetic testing which claims could accurately show whether a person had a predisposition to certain cancers and other diseases.

Having once again received approval to sell its genetic testing kits, 23andMe, which has backing from a number of serious investors, including Facebook’s Yuri Milner, is now expanding to large pharmaceuticals by striking a deal with the company Genetech.

Read more

To category page